RHELION

Live / Applied — Non-final action mailed (as of 11 Nov 2026)

Now

Refused for now — an office action was mailed 11 Nov 2026.

A response is due by 11 Feb 2027; with no response the application is abandoned.

What this means for you

Not registered yet, but its 26 Jun 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
99908955
Mark type
Word mark
Filed
26 Jun 2026
Attorney of record
Andrea Gorrie

Goods and services

  • Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of menopausal symptoms, menstrual symptoms, chemical dependency and drug addiction, eating disorders, Alzheimer's disease, Huntington's disease, and cerebral palsy, brain injuries, spinal cord injuries, and seizure disorders, stroke, Parkinson's disease, multiple sclerosis, myasthenia gravis, and Huntington's disease, mood disorders, anxiety disorders, cognitive disorders, schizophrenia, and bipolar disorder; Pharmaceutical preparations for the treatment of central nervous system disorders namely, encephalitis, epilepsy, Alzheimer's disease, cerebral palsy, and Parkinson's disease; Nutraceuticals for use as a dietary supplement for general health and well-being
  • Class 042 — Scientific and technological services: Medical research; Pharmaceutical drug development services

Owner

Prosecution history

  • 11 Nov 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
  • 11 Nov 2026 — NON-FINAL ACTION E-MAILED
  • 11 Nov 2026 — NON-FINAL ACTION WRITTEN
  • 31 Oct 2026 — ASSIGNED TO EXAMINER
  • 26 Oct 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
  • 26 Jun 2026 — APPLICATION FILING RECEIPT MAILED
  • 26 Jun 2026 — NEW APPLICATION ENTERED

View this trademark record on Rightsy